Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Varma, Ankur [1 ]
Saini, Neeraj Y. [1 ]
Sui, Dawen [2 ]
Milton, Denai R. [2 ]
Hasan, Omar [1 ]
Mukherjee, Akash [1 ]
Bashir, Qaiser [1 ]
Rondon, Gabriela [1 ]
Srour, Samer A. [1 ]
Popat, Uday [1 ]
Hosing, Chitra [1 ]
Nieto, Yago [1 ]
Kebriaei, Partow [1 ]
Alousi, Amin M. [1 ]
Mehta, Rohtesh S. [1 ]
Khouri, Issa F. [1 ]
Weber, Donna M. [3 ]
Thomas, Sheeba K. [3 ]
Manasanch, Elisabet E. [3 ]
Lee, Hans C. [3 ]
Patel, Krina K. [3 ]
Ciurea, Stefan O. [1 ]
Shpall, Elizabeth J. [1 ]
Orlowski, Robert Z. [3 ]
Champlin, Richard E. [1 ]
Qazilbash, Muzaffar H. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-115457
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4609
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Cardiac Toxicity of High-Dose Cyclophosphamide in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation
    Samo Zver
    Vesna Zadnik
    Matjaz Bunc
    Polona Rogel
    Peter Cernelc
    Mirta Kozelj
    International Journal of Hematology, 2007, 85 : 408 - 414
  • [22] Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation
    Zver, Samo
    Zadnik, Vesna
    Bunc, Matjaz
    Rogel, Polona
    Cernelc, Peter
    Kozelj, Mirta
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 85 (05) : 408 - 414
  • [23] Pegfilgrastim versus filgrastim to accelerate hematopoietic recovery after high-dose melphalan and autologous hematopoietic stem cell transplantation (ASCT) for multiple myeloma
    Olin, RL
    Luger, SM
    Porter, DL
    Schuster, SJ
    Tsai, D
    Nasta, S
    Perl, A
    Loren, AW
    Goldstein, S
    Mangan, P
    Sherry, V
    Cunningham, K
    Sachs, B
    Hummel, K
    Stadtmauer, EA
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 87 - 87
  • [24] Arsenic trioxide with ascorbic acid and high-dose melphalan for autologous hematopoietic stem cell transplantation for multiple myeloma
    Qazilbash, M. H.
    Jindani, S.
    Gul, Z.
    Saliba, R.
    Hosing, C.
    Mendoza, F.
    Qureshi, S. P.
    Weber, D. M.
    Wang, M.
    Flosser, T.
    Couriel, D. P.
    Kebriaei, P.
    Popat, U.
    Alousi, A. M.
    De Lima, M.
    Champlin, R. E.
    Giralt, S. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 9 - 10
  • [25] High-dose melphalan on day 2 versus 1 before autologous stem cell transplantation for multiple myeloma
    Rakszawski, K.
    Drabick, J. J.
    Dolloff, N. G.
    Sivik, J. M.
    Malysz, J.
    Claxton, D.
    Ehmann, W. C.
    Rybka, W. B.
    Talamo, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma
    Veltri, Lauren W.
    Milton, Denai R.
    Delgado, Ruby
    Shah, Nina
    Patel, Krina
    Nieto, Yago
    Kebriaei, Partow
    Popat, Uday R.
    Parmar, Simrit
    Oran, Betul
    Ciurea, Stefan
    Hosing, Chitra
    Lee, Hans C.
    Manasanch, Elisabet
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    Bashir, Qaiser
    CANCER, 2017, 123 (18) : 3568 - 3575
  • [27] High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis
    Shevchenko, Yury L.
    Novik, Andrei A.
    Kuznetsov, Aleksey N.
    Afanasiev, Boris V.
    Lisukov, Igor A.
    Kozlov, Vladimir A.
    Rykavicin, Oleg A.
    Ionova, Tatyana I.
    Melnichenko, Vladimir Y.
    Fedorenko, Denis A.
    Kulagin, Alexander D.
    Shamanski, Sergei V.
    Ivanov, Roman A.
    Gorodokin, Gary
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (08) : 922 - 928
  • [28] The Result of a Phase 1 Study of Selinexor in Combination with High-Dose Melphalan and Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
    Nishihori, Taiga
    Alsina, Melissa
    Ochoa, Jose
    Puglianini, Omar Alexis Castaneda
    Baz, Rachid
    Shain, Kenneth H.
    Brayer, Jason B.
    Kim, Jongphil
    Dumala, Michael
    Turner, Joel G.
    Sullivan, Daniel M.
    BLOOD, 2019, 134
  • [29] Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma
    Wu, Ka Lung
    Beverloo, Berna
    Lokhorst, Henk M.
    Segeren, Christine M.
    van der Holt, Bronno
    Steijaert, Monique M.
    Westveer, Petra H.
    Poddighe, Pino J.
    Verhoef, Gregor E.
    Sonneveld, Pieter
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (04) : 615 - 623
  • [30] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA WITH RENAL FAILURE
    Pokrovskaya, O.
    Mendeleeva, L.
    Urnova, E.
    Firsova, M.
    Nareyko, M.
    Kuzmina, L.
    Rekhtina, I.
    Tauson, I.
    Varlamova, E.
    Parovichnikova, E.
    Savchenko, V.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S345 - S346
12345